[1]李泽艳,王晓旋,来明名,等.基于生物信息学分析HLA-DMA基因在LGG中的表达和功能[J].医学信息,2021,(24):21-26.[doi:10.3969/j.issn.1006-1959.2021.24.005]
 LI Ze-yan,WANG Xiao-xuan,LAI Ming-ming,et al.Expression and Function of HLA-DMA Gene in LGG Based on Bioinformatics Analysis[J].Medical Information,2021,(24):21-26.[doi:10.3969/j.issn.1006-1959.2021.24.005]
点击复制

基于生物信息学分析HLA-DMA基因在LGG中的表达和功能()
分享到:

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
期数:
2021年24期
页码:
21-26
栏目:
论著
出版日期:
2021-12-15

文章信息/Info

Title:
Expression and Function of HLA-DMA Gene in LGG Based on Bioinformatics Analysis
文章编号:
1006-1959(2021)24-0021-06
作者:
李泽艳王晓旋来明名
(大理大学基础医学院,云南 大理 671000)
Author(s):
LI Ze-yanWANG Xiao-xuanLAI Ming-minget al.
(School of Basic Medical Sciences,Dali University,Dali 671000,Yunnan,China)
关键词:
LGGHLA-DMA免疫调节
Keywords:
LGGHLA-DMAImmunoregulation
分类号:
R739.41
DOI:
10.3969/j.issn.1006-1959.2021.24.005
文献标志码:
A
摘要:
目的 基于生物信息学方法探讨HLA-DMA基因在低级别脑胶质瘤(LGG)中的表达和功能。方法 基于GEPIA数据库分析HLA-DMA在LGG和正常组织中的表达差异;从TCGA数据库中下载正常组织和LGG组织基因表达数据和临床资料,采用R软件分析HLA-DMA表达水平与临床病理特征和预后的关系;利用Coexpedia构建HLA-DMA在LGG中的共表达基因网络,并用FunRich软件对共表达基因进行注释;借助GSEA探讨HLA-DMA参与的信号通路。结果 LGG组织中HLA-DMA表达高于正常组织,差异有统计学意义(P<0.05),且与肿瘤分级和预后相关;单、多因素Cox分析显示,HLA-DMA可作为LGG患者的独立预后因素 (P<0.05);HLA-DMA与共表达基因所参与的分子生物学功能主要与免疫调节相关;GSEA结果显示,HLA-DMA高表达主要富集于免疫调节相关通路和凋亡通路。结论 HLA-DMA在LGG中呈高表达,可作为LGG治疗和预后评估的潜在靶点。
Abstract:
Objective To explore the expression and function of HLA-DMA gene in low-grade glioma (LGG) based on bioinformatics methods.Methods The expression differences of HLA-DMA in LGG and normal tissues were analyzed based on GEPIA database. The gene expression data and clinical data of normal tissues and LGG tissues were downloaded from TCGA database. The relationship between HLA-DMA expression level and clinicopathological features and prognosis was analyzed by R software. The co-expression gene network of HLA-DMA in LGG was constructed by Coexpedia and annotated by FunRich software. The signaling pathway involved in HLA-DMA were explored by GSEA.Results The expression of HLA-DMA in LGG tissues was higher than that in normal tissues, and the difference was statistically significant (P<0.05), which was related to tumor grade and prognosis. Univariate and multivariate Cox analysis showed that HLA-DMA was an independent prognostic factor for LGG patients (P<0.05). The molecular biological functions of HLA-DMA and co-expression genes are mainly related to immune regulation; gSEA results showed that the high expression of HLA-DMA was mainly enriched in immune regulation-related pathways and apoptosis pathways.Conclusion HLA-DMA is highly expressed in LGG, which can be used as a potential target for LGG treatment and prognosis evaluation.

参考文献/References:

[1]Wen PY,Huse JT.2016 World Health Organization Classification of Central Nervous System Tumors[J].Continuum (Minneap Minn),2017,23(6):1531-1547.[2]Youssef G,Miller JJ.Lower Grade Gliomas[J].Curr Neurol Neurosci Rep,2020,20(7):21. [3]Burak Atci I,Yilmaz H,Samanci MY.The top 50 most-cited articles on low-grade glioma: a bibliometric analysis[J].Br J Neurosurg,2019,33(2):171-175.[4]Budia I,Alvarez-Arenas A,Woolley TE,et al.Radiation protraction schedules for low-grade gliomas: a comparison between different mathematical models[J].J R Soc Interface,2019,16(161):20190665.[5]Garcia CR,Slone SA,Pittman T,et al.Comprehensive evaluation of treatment and outcomes of low-grade diffuse gliomas[J].PLoS One,2018,13(9):e0203639.[6]Jin YP,Valenzuela NM,Zhang X,et al.HLA Class II-Triggered Signaling Cascades Cause Endothelial Cell Proliferation and Migration: Relevance to Antibody-Mediated Transplant Rejection[J].J Immunol,2018,200(7):2372-2390.[7]Ramia E,Chiaravalli AM,Bou Nasser Eddine F,et al.CIITA-related block of HLA class II expression, upregulation of HLA class I, and heterogeneous expression of immune checkpoints in hepatocarcinomas: implications for new therapeutic approaches[J].Oncoimmunology,2018,8(3):1548243.[8]Cioni B,Jordanova ES,Hooijberg E,et al.HLA class II expression on tumor cells and low numbers of tumor-associated macrophages predict clinical outcome in oropharyngeal cancer[J].Head Neck,2019,41(2):463-478.[9]Garrido F.HLA Class-II Expression in Human Tumors[J].Adv Exp Med Biol,2019(1151):91-95.[10]郭传军.HLA-DMA rs1063478位点多态性与胶质瘤易感性及mTOR通路与高级别胶质瘤预后的关系[D].济南:山东大学,2016.[11]Wang Q,He Z,Chen Y.Comprehensive Analysis Reveals a 4-Gene Signature in Predicting Response to Temozolomide in Low-Grade Glioma Patients[J].Cancer Control,2019,26(1):1073274819855118.[12]Wang S,Jin F,Fan W,et al.Gene expression meta-analysis in diffuse low-grade glioma and the corresponding histological subtypes[J].Sci Rep,2017,7(1):11741.[13]Jakola AS,Skjulsvik AJ,Myrmel KS,et al.Surgical resection versus watchful waiting in low-grade gliomas[J].Ann Oncol,2017,28(8):1942-1948.[14]Xu B.Prediction and analysis of hub genes between glioblastoma and low-grade glioma using bioinformatics analysis[J].Medicine,2021,100(3):e23513.[15]Xu X,Lai Y,Hua ZC.Apoptosis and apoptotic body: disease message and therapeutic target potentials[J].Biosci Rep,2019,39(1):BSR20180992.[16]Villanova L,Careccia S,De Maria R,et al.Micro-Economics of Apoptosis in Cancer: ncRNAs Modulation of BCL-2 Family Members[J].Int J Mol Sci,2018,19(4):958.[17]Carneiro BA,El-Deiry WS.Targeting apoptosis in cancer therapy[J].Nat Rev Clin Oncol,2020,17(7):395-417.[18]Pfeffer CM,Singh ATK.Apoptosis: A Target for Anticancer Therapy[J].Int J Mol Sci,2018,19(2):448. [19]Cao LJ,Xie HT,Chu ZX,et al.Tubeimoside-1 induces apoptosis in human glioma U251 cells by suppressing PI3K/Akt-mediated signaling pathways[J].Mol Med Rep,2020,22(2):1527-1535.[20]Liu Y,Yaozu Z,Zhao H,et al.Inhibition of Glioma Cell Growth and Apoptosis Induction through Targeting Wnt10B Expression by Pyrazolo[4,3-c]pyridine-4-one[J].Med Sci Monit,2020(26):e923912.

更新日期/Last Update: 1900-01-01